RT Journal Article
SR Electronic
T1 The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP S4
OP S10
DO 10.3949/ccjm.83.s1.02
VO 83
IS 5 suppl 1
A1 Sandler, Courtney Nagel
A1 McDonnell, Marie E.
YR 2016
UL http://www.ccjm.org/content/83/5_suppl_1/S4.abstract
AB Hemoglobin A1c (HbA1c) is a widely used tool for diagnosing, screening, and managing patients with diabetes; however, proper application and interpretation of the HbA1c test is crucial to master for accurate assessment of patients. It also has become the standard test in population-based studies for evaluating the relationship between glycemic control and cardiovascular risk. Result from large clinical trials support the modern perspective that the HbA1c target should be personalized according to the risks and benefits of glycemic control. This likely is most important in patients with diabetes and elevated cardiovascular risk in whom achieving low HbA1c levels early in the natural history may be the most beneficial.